Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors
Clinical trial NCT04446351 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04446351
- Sponsor
- GlaxoSmithKline
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-25
- Primary completion
- 2026-12-31
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.